PCV11 EVALUATING CLINICAL OUTCOMES FOR SUBJECTS THAT ARE NEWLY INITIATED ON HMG-COA REDUCTASE INHIBITORS IN A NATURALISTIC ENVIRONMENT USING LONGITUDINAL DESIGN
I Al-Zakwani, MF Bullano, VJ Willey, MJ Cziraky, L HoffmanVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)62377-7
File:
PDF, 45 KB
english, 2004